GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?
Journal of Medical Internet Research · 19.10.2026 · 28 · e113477-e113477
DOI: 10.2196/113477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 19.10.2026. Verfasst von Anna Zucker. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Body Image, Advertising. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
GLP-1 medications are incredibly accessible—while this may be a net positive for eligible patients, their widespread marketing may not be. In this News and Perspectives article, JMIR Correspondent Anna Zucker reports on concerns being raised about the potential impact of GLP-1 marketing practices on body image and well-being.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Zucker, A. (2026). GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?. Journal of Medical Internet Research, 28, e113477-e113477. https://doi.org/10.2196/113477
Vancouver
Zucker A. GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?. Journal of Medical Internet Research. 2026;28:e113477-e113477. doi:10.2196/113477
BibTeX
@article{Zucker2026,
author = {Zucker, Anna},
title = {GLP-1 Ads Are Everywhere. What Are They Doing to Our Body Image?},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e113477--e113477},
doi = {10.2196/113477}
}
EUVIMED